BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22548675)

  • 1. Systematic review and meta-analysis of randomized trials on probiotics for hepatic encephalopathy.
    Holte K; Krag A; Gluud LL
    Hepatol Res; 2012 Oct; 42(10):1008-15. PubMed ID: 22548675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotics for patients with hepatic encephalopathy.
    McGee RG; Bakens A; Wiley K; Riordan SM; Webster AC
    Cochrane Database Syst Rev; 2011 Nov; (11):CD008716. PubMed ID: 22071855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis.
    Zacharias HD; Zacharias AP; Gluud LL; Morgan MY
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012334. PubMed ID: 31204790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
    Gluud LL; Vilstrup H; Morgan MY
    Cochrane Database Syst Rev; 2016 Apr; 4():CD003044. PubMed ID: 27089005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Branched-chain amino acids for people with hepatic encephalopathy.
    Gluud LL; Dam G; Les I; Marchesini G; Borre M; Aagaard NK; Vilstrup H
    Cochrane Database Syst Rev; 2017 May; 5(5):CD001939. PubMed ID: 28518283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Branched-chain amino acids for people with hepatic encephalopathy.
    Gluud LL; Dam G; Les I; Córdoba J; Marchesini G; Borre M; Aagaard NK; Vilstrup H
    Cochrane Database Syst Rev; 2015 Feb; (2):CD001939. PubMed ID: 25715177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Branched-chain amino acids for people with hepatic encephalopathy.
    Gluud LL; Dam G; Les I; Córdoba J; Marchesini G; Borre M; Aagaard NK; Vilstrup H
    Cochrane Database Syst Rev; 2015 Sep; (9):CD001939. PubMed ID: 26377410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy.
    Shukla S; Shukla A; Mehboob S; Guha S
    Aliment Pharmacol Ther; 2011 Mar; 33(6):662-71. PubMed ID: 21251030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotics and synbiotics for the prevention of postoperative infections following abdominal surgery: a systematic review and meta-analysis of randomized controlled trials.
    Lytvyn L; Quach K; Banfield L; Johnston BC; Mertz D
    J Hosp Infect; 2016 Feb; 92(2):130-9. PubMed ID: 26601607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probiotics for the prevention of pediatric antibiotic-associated diarrhea.
    Goldenberg JZ; Lytvyn L; Steurich J; Parkin P; Mahant S; Johnston BC
    Cochrane Database Syst Rev; 2015 Dec; (12):CD004827. PubMed ID: 26695080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotics for the Prevention of Pediatric Antibiotic-Associated Diarrhea.
    Hayes SR; Vargas AJ
    Explore (NY); 2016; 12(6):463-466. PubMed ID: 27688016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of probiotics in the treatment of minimal hepatic encephalopathy: A systematic review and meta-analysis.
    Wibawa IDN; Mariadi IK; Shalim CP; Sindhughosa DA
    Clin Exp Hepatol; 2023 Jun; 9(2):146-153. PubMed ID: 37502435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probiotics are helpful in hepatic encephalopathy: a meta-analysis of randomized trials.
    Saab S; Suraweera D; Au J; Saab EG; Alper TS; Tong MJ
    Liver Int; 2016 Jul; 36(7):986-93. PubMed ID: 26561214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review).
    Gordon M; Naidoo K; Akobeng AK; Thomas AG
    Evid Based Child Health; 2013 Jan; 8(1):57-109. PubMed ID: 23878124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of oral supplementation with probiotics or synbiotics in overweight and obese adults: a systematic review and meta-analyses of randomized trials.
    Suzumura EA; Bersch-Ferreira ÂC; Torreglosa CR; da Silva JT; Coqueiro AY; Kuntz MGF; Chrispim PP; Weber B; Cavalcanti AB
    Nutr Rev; 2019 Jun; 77(6):430-450. PubMed ID: 30924853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis.
    Ford AC; Quigley EM; Lacy BE; Lembo AJ; Saito YA; Schiller LR; Soffer EE; Spiegel BM; Moayyedi P
    Am J Gastroenterol; 2014 Oct; 109(10):1547-61; quiz 1546, 1562. PubMed ID: 25070051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy: a meta-analysis.
    Luo M; Li L; Lu CZ; Cao WK
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1250-7. PubMed ID: 21971378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A meta-analysis of microbiome therapies for hepatic encephalopathy.
    Gao J; Nie R; Chang H; Yang W; Ren Q
    Eur J Gastroenterol Hepatol; 2023 Sep; 35(9):927-937. PubMed ID: 37505972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of different drugs in the treatment of minimal hepatic encephalopathy: A network meta-analysis involving 826 patients based on 10 randomized controlled trials.
    Cai XJ; Wang L; Hu CM
    J Cell Biochem; 2018 Nov; 119(10):8336-8345. PubMed ID: 29932239
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.